| Customization: | Available |
|---|---|
| Package: | 4AMP/Box |
| Composition: | Edaravone |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product | Dose | Package |
| Edaravone Injection | 20ml/30mg | 4Amp/box |
Edaravone injection is a sterile solution containing the active ingredient edaravone, a free radical scavenger and antioxidant. It is indicated for the treatment of two distinct neurological conditions: amyotrophic lateral sclerosis (ALS) and acute ischemic stroke.
Edaravone injection may be indicated for:
Amyotrophic Lateral Sclerosis (ALS): ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder affecting motor neurons in the brain and spinal cord. Edaravone injection is used as a treatment to slow the progression of functional impairment in patients with ALS.
Acute Ischemic Stroke: Edaravone injection is indicated for the treatment of acute ischemic stroke in adult patients. It is administered within a specific time window following the onset of symptoms and is intended to reduce neuronal damage and improve neurological outcomes.
Administration:
Edaravone injection is typically administered intravenously under the supervision of a healthcare professional. The dosage and administration regimen may vary depending on the patient's condition, medical history, and the judgment of the prescribing physician.
As with any medication, edaravone injection should be used with caution and under the guidance of a qualified healthcare provider. Special consideration should be given to patients with allergies to edaravone or other underlying medical conditions.
){kind=link}